Tools such as MRI scans and computerized 3-D models are used to perform tests for some common conditions including Down syndrome, Parkinson's disease, brain tumors, effects of stroke such as, language loss and many others.

Download PDF Brochure of Research Study Here

AI is increasingly adopted into methods that manage and make sense of brain activity. AI abstracts high-level concepts of what we think our brains do, even if how algorithms go about their computation is vastly different from us.

• Motion and manipulation

AI is heavily used in robotics. Advanced robotic arms and other industrial robots, widely used in modern hospitals, can learn from experience how to move efficiently for surgeries.

A modern mobile robot, when given a small, static, and visible environment, can easily determine its location and map its environment; however, dynamic environments, such as (in endoscopy) the interior of a patient's breathing body, pose a greater challenge. Motion planning is the process of breaking down a movement task into "primitives" such as individual joint movements. Such movement often involves compliant motion, a process where movement requires maintaining physical contact with an object.

• AI and Robotics Surgeries

According to CNN, a recent study by surgeons at the Children's National Medical Center in Washington successfully demonstrated surgery with an autonomous robot. The team supervised the robot while it performed soft-tissue surgery, stitching together a pig's bowel during open surgery, and doing so better than a human surgeon, the team claimed. IBM has created its own artificial intelligence computer, the IBM Watson, which has beaten human intelligence (at some levels). Watson has struggled to achieve success and adoption in healthcare.

• Hospitality

In the hospitality industry, Artificial Intelligence based solutions are used to reduce staff load and increase efficiency by cutting repetitive tasks frequency, trends analysis, guest interaction, and customer needs prediction. Hotel services backed by Artificial Intelligence are represented in the form of a chatbot, application, virtual voice assistant and service robots.

• Artificial brain

An artificial brain (or artificial mind) is software and hardware with cognitive abilities similar to those of the animal or human brain. An example of the first objective is the project reported by Aston University in Birmingham, England where researchers are using biological cells to create "neurospheres" (small clusters of neurons) in order to develop new treatments for diseases including Alzheimer's, motor neurone and Parkinson's disease.

Get PDF Brochure of Study, Click Here

3D Bioprinting refers to the three-dimensional printing of a biological tissue and organ done with the help of living cells, through organ transplantation and tissue engineering. It mainly utilizes layer-by-layer method, computed tomography (CT) and magnetic resonance imaging (MRI) techniques.

3D Bioprinting is used to print tissues and organs that helps during drug and pills research and has also begun to include the printing of scaffolds that can be used to regenerate joints and ligaments.

The 3D Bioprinting market is anticipated to grow in the forecast, owing to the factors such as growing elderly population, rising demand for organ transplant, technological advancements and innovations and improving R&D activities.

Get PDF Brochure of Research Study, Click Here

In medicine, for example, the ability to analyze large data sets helps drug makers identify treatments based on the cause of a disease. In addition, the evolution of cloud computing technology has removed a barrier for many innovations in biotech. The ability to run applications through the cloud allows companies to store and analyze data without buying expensive computer hardware.

This benefits early-stage startups, which try to limit operating expenses as much as possible, but it also helps larger and more established companies, as it makes it easier and cheaper to allocate resources for new projects.

Computational Biomodeling

Computational biomodeling is a field concerned with building computer models of biological systems. Computational biomodeling aims to develop and use visual simulations in order to assess the complexity of biological systems. This is accomplished through the use of specialized algorithms, and visualization software. These models allow for prediction of how systems will react under different environments. This is useful for determining if a system is robust.

A robust biological system is one that “maintain their state and functions against external and internal perturbations”, which is essential for a biological system to survive. Computational biomodeling generates a large archive of such data, allowing for analysis from multiple users.

While current techniques focus on small biological systems, researchers are working on approaches that will allow for larger networks to be analyzed and modeled. A majority of researchers believe that this will be essential in developing modern medical approaches to creating new drugs and gene therapy. A useful modelling approach is to use Petri nets via tools such as esyN.

Computational genomics

Computational genomics is a field within genomics which studies the genomes of cells and organisms. It is sometimes referred to as Computational and Statistical Genetics and encompasses much of Bioinformatics.

The Human Genome Project is one example of computational genomics. This project looks to sequence the entire human genome into a set of data. Once fully implemented, this could allow for doctors to analyze the genome of an individual patient. This opens the possibility of personalized medicine, prescribing treatments based on an individual's pre-existing genetic patterns. This project has created many similar programs. Researchers are looking to sequence the genomes of animals, plants, bacteria, and all other types of life.

source: northeastern, Wiki, The Insight partners

Download PDF Brochure of Study, Click Here

Gene prediction

Metagenomic analysis pipelines use two approaches in the annotation of coding regions in the assembled contigs. The first approach is to identify genes based upon homology with genes that are already publicly available in sequence databases, usually by BLAST searches. This type of approach is implemented in the program MEGAN4.

The second, ab initio, uses intrinsic features of the sequence to predict coding regions based upon gene training sets from related organisms. This is the approach taken by programs such as GeneMark and GLIMMER. The main advantage of ab initio prediction is that it enables the detection of coding regions that lack homologs in the sequence databases; however, it is most accurate when there are large regions of contiguous genomic DNA available for comparison.

Shotgun metagenomics

Advances in bioinformatics, refinements of DNA amplification, and the proliferation of computational power have greatly aided the analysis of DNA sequences recovered from environmental samples, allowing the adaptation of shotgun sequencing to metagenomic samples (known also as whole metagenome shotgun or WMGS sequencing).

The approach, used to sequence many cultured microorganisms and the human genome, randomly shears DNA, sequences many short sequences, and reconstructs them into a consensus sequence. Shotgun sequencing reveals genes present in environmental samples.

Historically, clone libraries were used to facilitate this sequencing. However, with advances in high throughput sequencing technologies, the cloning step is no longer necessary and greater yields of sequencing data can be obtained without this labour-intensive bottleneck step. Shotgun metagenomics provides information both about which organisms are present and what metabolic processes are possible in the community.

Because the collection of DNA from an environment is largely uncontrolled, the most abundant organisms in an environmental sample are most highly represented in the resulting sequence data. To achieve the high coverage needed to fully resolve the genomes of under-represented community members, large samples, often prohibitively so, are needed.

Want to Know more about Metagenomics ?

Download PDF Sample of Study, Click Here

Download PDF Brochure of Study, Click Here

Epigenetic data processing and analysis

Various experimental techniques have been developed for genome-wide mapping of epigenetic information, the most widely used being ChIP-on-chip, ChIP-seq and bisulfite sequencing. All of these methods generate large amounts of data and require efficient ways of data processing and quality control by bioinformatic methods.

Epigenome prediction

A substantial amount of bioinformatic research has been devoted to the prediction of epigenetic information from characteristics of the genome sequence. Such predictions serve a dual purpose. First, accurate epigenome predictions can substitute for experimental data, to some degree, which is particularly relevant for newly discovered epigenetic mechanisms and for species other than human and mouse.

Second, prediction algorithms build statistical models of epigenetic information from training data and can therefore act as a first step toward quantitative modeling of an epigenetic mechanism. Successful computational prediction of DNA and lysine methylation and acetylation has been achieved by combinations of various features.

Segmentation, By Product

• Reagents
• Kits
• Enzymes
• Instruments & Consumables
• Bioinformatics Tools

By Technology

• Histone Modification
• DNA Methylation

Applications

• Oncology
• Cardiovascular Diseases

End Users

• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
• Contract Research Organization

Want to Know more about Computational Epigenetics ?

Get full information and PDF Sample of Computational Epigenetics

Declining Prices of Sequencing

The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. The costs associated with DNA sequencing performed at the sequencing centers, which is funded by the Institutes, has tracked by the National Human Genome Research Institute (NHGRI) for many years.

This information has served as a key standard for establishing the DNA sequencing capacity and considering improvements in DNA sequencing technologies of the NHGRI Genome Sequencing Program (GSP). In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion.

However, the costs for the same in recent years has reduce to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.

Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market.

Source: Wiki & The Insight Partners

Get PDF Brochure of Research Study, Click Here

Generally, 3D bioprinting utilizes the layer-by-layer method to deposit materials known as bioinks to create tissue-like structures that are later used in medical and tissue engineering fields. Bioprinting covers a broad range of biomaterials.

Technological Advancements in the Field of 3D Tissue Engineering

3D bioprinting has rapidly transformed the healthcare sector in the last few years. This technology has advanced the development of tissue with clinical potential, paving the way for high-throughput applications for drug discovery.

3D bioprinting tissue-engineering helps in the healing of injuries; new breakthroughs in the 3D printing technique are projected to offer a potential treatment option for organ failure in future. Many research organizations are working toward finding new therapies to treat organ failure and repair cells of damaged tissues.

For instance, in 2017, researchers at Penn State University discovered a revolutionary way to print tissues and organs with the use of an “electrospinning printer” that spins fibers seeded with cells to create fiber layers. This technology is both cheaper and offers an opportunity to spin polymer fibers such as collagen layers with precision and in a more controlled manner.

Innovative handheld 3D bioprinter treats serious burns

The new system which is in the early stages of development may become a way to treat patients whose burn injuries are too extensive to allow skin grafts.

Printing new skin cells on a burn injury may eventually become the new treatment to treat burns, shared a team of researchers from Canada. They have successfully tested the newly developed 'handheld 3D printer'.

The new system which is in the early stages of development may become a way to treat patients whose burn injuries are too extensive to allow skin grafts. The results are reported on Monday (local time) in the IOP publishing journal Biofabrication.

Senior author and professor Axel Gunther, from the University of Toronto, said, "Skin grafts, where the damaged tissue is removed and replaced with skin taken from another area of the patient's body, are a standard treatment for serious burns.

The senior author also shared that while there are alternatives - including scaffolds using bovine collagen or engineered skin substitutes grown in vitro - none are ideal. To overcome these challenges, the research team designed the handheld device to deposit precursor sheets directly onto wounds of any size, shape or topography.

Co-author Dr Marc Jeschke, medical director of the Ross Tilley Burn Centre at Sunnybrook Health Sciences Centre in Toronto, said, "In general, the wound surfaces we designed this device for are not flat, nor are they oriented horizontally. One of the most important advantages of the device is that it should allow for the uniform deposition of a bioink layer onto inclined surfaces.

Marc continued saying that in this study, we tested whether the device could do this effectively by using it to treat full-thickness burns in pigs. We found the device successfully deposited the 'skin sheets' onto the wounds uniformly, safely and reliably, and the sheets stayed in place with only very minimal movement.

"Most significantly, our results showed that the MSC-treated wounds healed extremely well, with a reduction in inflammation, scarring, and contraction compared with both the untreated wounds and those treated with a collagen scaffold," the co-author opined.

The researchers are extremely pleased by the success as well as the excellent healing outcomes of the test.

"However, in cases where a patient has extensive full-thickness burns — which destroy both the upper and lower layers of the skin -— here is not always sufficient healthy skin left to use," Axel added.

Download PDF Brochure of Research Study, Click Here

Developments in nanotechnology are opening up the prospects for nanomedicine and regenerative medicine where informatics and DNA computing can become the catalysts enabling health care applications at sub-molecular or atomic scales.

Nanoinformatics: an emerging area of information technology at the intersection of Bioinformatics, Computational Chemistry and Nanobiotechnology.

Nanoinformatics can accelerate the introduction of nano-related research and applications into clinical practice, leading to an area that could be called “translational nanoinformatics.” At the same time, DNA and RNA computing presents an entirely novel paradigm for computation.

Nanoinformatics and DNA-based computing are together likely to completely change the way we model and process information in biomedicine and impact the emerging field of nanomedicine most strongly.

A new generation of nanodevices for diagnosing and treating children with genetic diseases and cancer includes the use of nanoparticles for diagnostic imaging during pregnancy, nano-based newborn screening tests for genetic abnormalities and mutation detection for cystic fibrosis using a nanoparticle based bio-sensing system. Similarly, nanomechanical approaches study the effect of drugs on Pseudomonas aeruginosa, the causative agent of chronic lung infections in patients affected by cystic fibrosis.

Nanoinformatics can contribute critically to some of the above. Examples include: describing the use of computer simulations for improving targeted delivery of magnetic aerosol droplets to specific lung regions to treat asthma, cystic fibrosis, respiratory infection, or lung cancer. Stone et al. analyzed the potential toxicity of air pollution nanoparticles in children and adults in terms of cellular and molecular interactions involved in inducing oxidative stress and inflammation.

SCOPE

The "Global Nanomedicines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of nanomedicines market with detailed market segmentation by product, application, type, and geography. The global nanomedicines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nanomedicines market players and offers key trends and opportunities in the market.

DYNAMICS

The nanomedicines market is anticipated to grow in the forecast period owing to driving factors such as, large amount of R&D happen in this field and the rising number of cases of cancer. The new applications of nanodevices are expected to offer significant growth opportunities in the global nanomedicines market during the forecast period.

Nanoinformatics and DNA-Based Computing: Catalyzing Nanomedicine

Want to Know more about Nanoinformatics and Bioinformatics??? Just go through the Link- https://bit.ly/2EoIFix

Source: The Insight Partners & nature.com

This potential of human embryonic stem cell allows them to provide an unlimited amount of tissue for transplantation therapies to treat a wide range of degenerative diseases.

Hence, human embryonic stem cells are used in the treatment of various diseases such as Alzheimer's disease, cancer, blood and genetic disorders related to the immune system and others.

Download PDF Brochure of PDF Research Study, Click Here

Derivation from Humans

In vitro fertilization generates multiple embryos. The surplus of embryos is not clinically used or is unsuitable for implantation into the patient, and therefore may be donated by the donor with consent.

Human embryonic stem cells can be derived from these donated embryos or additionally they can also be extracted from cloned embryos using a cell from a patient and a donated egg.

The inner cell mass (cells of interest), from the blastocyst stage of the embryo, is separated from the trophectoderm, the cells that would differentiate into extra-embryonic tissue.

Immunosurgery, the process in which antibodies are bound to the trophectoderm and removed by another solution, and mechanical dissection are performed to achieve separation. The resulting inner cell mass cells are plated onto cells that will supply support. The inner cell mass cells attach and expand further to form a human embryonic cell line, which are undifferentiated.

These cells are fed daily and are enzymatically or mechanically separated every four to seven days. For differentiation to occur, the human embryonic stem cell line is removed from the supporting cells to form embryoid bodies, is co-cultured with a serum containing necessary signals, or is grafted in a three-dimensional scaffold to result.

Contamination by reagents used in cell culture

The online edition of Nature Medicine published a study on January 24, 2005, which stated that the human embryonic stem cells available for federally funded research are contaminated with non-human molecules from the culture medium used to grow the cells. It is a common technique to use mouse cells and other animal cells to maintain the pluripotency of actively dividing stem cells.

The problem was discovered when non-human sialic acid in the growth medium was found to compromise the potential uses of the embryonic stem cells in humans, according to scientists at the University of California, San Diego.

However, a study published in the online edition of Lancet Medical Journal on March 8, 2005 detailed information about a new stem cell line that was derived from human embryos under completely cell- and serum-free conditions.

After more than 6 months of undifferentiated proliferation, these cells demonstrated the potential to form derivatives of all three embryonic germ layers both in vitro and in teratomas. These properties were also successfully maintained (for more than 30 passages) with the established stem cell lines.

Source: Wiki & The Insight Partners

Download PDF Brochure of Research Study

All of these factors modulate gene expression in a tissue-specific manner. Bioinformatics is a successful approach in the field of molecular biology for studying epigenomics data. To generate these epigenomic data which can be analyzed using various bioinformatics tools and software, a variety of technologies are being used by researchers.

Many biological databases which store a huge amount of information related to the modifications due to epigenetics are available online. With the help of these data, we can identify key target genes that can be manipulated to achieve some resistance against diseases caused by epigenetic factors.

Epigenetic research uses a wide range of molecular biological techniques to further understanding of epigenetic phenomena, including chromatin immunoprecipitation (together with its large-scale variants ChIP-on-chip and ChIP-Seq), fluorescent in situ hybridization, methylation-sensitive restriction enzymes, DNA adenine methyltransferase identification (DamID) and bisulfite sequencing. Furthermore, the use of bioinformatics methods has a role in computational epigenetics.

Genetic Code

The similarity of the word to "genetics" has generated many parallel usages. The "epigenome" is a parallel to the word "genome", referring to the overall epigenetic state of a cell, and epigenomics refers to global analyses of epigenetic changes across the entire genome.

The phrase "genetic code" has also been adapted – the "epigenetic code" has been used to describe the set of epigenetic features that create different phenotypes in different cells from the same underlying DNA sequence. Taken to its extreme, the "epigenetic code" could represent the total state of the cell, with the position of each molecule accounted for in an epigenomic map, a diagrammatic representation of the gene expression, DNA methylation and histone modification status of a particular genomic region.

More typically, the term is used in reference to systematic efforts to measure specific, relevant forms of epigenetic information such as the histone code or DNA methylation patterns.

• Medicine

Epigenetics has many and varied potential medical applications. In 2008, the National Institutes of Health announced that $190 million had been earmarked for epigenetics research over the next five years.

In announcing the funding, government officials noted that epigenetics has the potential to explain mechanisms of aging, human development, and the origins of cancer, heart disease, mental illness, as well as several other conditions. Some investigators, like Randy Jirtle, Ph.D., of Duke University Medical Center, think epigenetics may ultimately turn out to have a greater role in disease than genetics.

source: springer & wiki

According to Wikipedia, Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data, in particular when the data sets are large and complex.

Get PDF Brochure of Study @ https://bit.ly/3cRbZt6

High-throughput single cell data analysis

Computational techniques are used to analyse high-throughput, low-measurement single cell data, such as that obtained from flow cytometry. These methods typically involve finding populations of cells that are relevant to a particular disease state or experimental condition.

Biodiversity informatics

Biodiversity informatics deals with the collection and analysis of biodiversity data, such as taxonomic databases, or microbiome data. Examples of such analyses include phylogenetics, niche modelling, species richness mapping, DNA barcoding, or species identification tools.

Ontologies and data integration

Biological ontologies are directed acyclic graphs of controlled vocabularies. They are designed to capture biological concepts and descriptions in a way that can be easily categorised and analysed with computers. When categorised in this way, it is possible to gain added value from holistic and integrated analysis.

The future of Bioinformatics is integration. For example, integration of a wide variety of data sources such as clinical and genomic data will allow us to use disease symptoms to predict genetic mutations and vice versa. The integration of GIS data, such as maps, weather systems, with crop health and genotype data, will allow us to predict successful outcomes of agriculture experiments. Another future area of research in bioinformatics is large-scale comparative genomics.

For example, the development of tools that can do 10-way comparisons of genomes will push forward the discovery rate in this field of bioinformatics. Along these lines, the modeling and visualization of full networks of complex systems could be used in the future to predict how the system (or cell) reacts, to a drug, for example.

A technical set of challenges faces bioinformatics and is being addressed by faster computers, technological advances in disk storage space, and increased bandwidth, but by far one of the biggest hurdles facing bioinformatics today, is the small number of researchers in the field. This is changing as bioinformatics moves to the forefront of research but this lag in expertise has lead to real gaps in the knowledge of bioinformatics in the research community.

Finally, a key research question for the future of bioinformatics will be how to computationally compare complex biological observations, such as gene expression patterns and protein networks.

Bioinformatics is about converting biological observations to a model that a computer will understand. This is a very challenging task since biology can be very complex. This problem of how to digitize phenotypic data such as behavior, electrocardiograms, and crop health into a computer readable form offers exciting challenges for future bioinformaticians.

source: scq.ubc.ca, wiki, towardsdatascience